重度抑郁症患者与对照人群的代谢组与肠道微生物组相互作用
该队列研究基于英国生物银行约500 000名参与者的代谢组数据,比较了6811例终生重度抑郁症(MDD)患者与51 446名对照的249种代谢物,发现124种代谢物与MDD相关,涉及能量与脂质代谢通路。孟德尔随机化提示脂肪酸及中/极大密度脂蛋白与疾病进程相关,而高密度脂蛋白和三羧酸循环代谢物不相关;肠道微生物组与血液代谢组的相互作用可能参与MDD的脂质代谢。
要点
- MDD患者存在124种代谢物改变,涉及能量与脂质代谢通路。
- 柠檬酸降低、丙酮酸升高提示三羧酸循环紊乱。
- 肠道菌群与血液代谢组互作可能参与MDD脂质代谢。
核心结论
- MDD患者存在能量代谢紊乱,肠道微生物组与血液代谢组的相互作用可能参与脂质代谢。
研究设计与样本
- 队列研究,使用英国生物银行约500 000名37至73岁参与者的代谢组数据,并在PREDICT和BBMRI-NL研究中重复。
- 孟德尔随机化使用2019年抑郁症全基因组关联研究汇总数据(MDD 59 851例,对照113 154例)。
- 代谢物汇总数据来自OpenGWAS的MRbase(n=118 000),肠道微生物组代谢特征来自2019年荷兰队列研究。
主要发现
- 终生MDD患者6811例与对照51 446例比较,复发MDD患者4370例与对照62 508例比较。
- MDD的代谢特征包括124种代谢物,涵盖能量与脂质代谢通路,其中49种为新发现,包括三羧酸循环中的柠檬酸和丙酮酸。
- MDD患者柠檬酸显著降低(β [SE],-0.07 [0.02];FDR=4×10^-4),丙酮酸显著升高(β [SE],0.04 [0.02];FDR=0.02)。
- 这些代谢物变化(尤其是脂蛋白)与梭菌目、变形菌门/假单胞菌门和拟杆菌门/拟杆菌门的肠道微生物组成差异一致。
- 孟德尔随机化提示脂肪酸及中密度和极大密度脂蛋白与疾病进程相关,而高密度脂蛋白和三羧酸循环代谢物不相关。
临床怎么用
- 提示临床关注MDD患者的能量与脂质代谢异常,以及肠道菌群可能作为干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Metabolomics reflect the net effect of genetic and environmental influences and thus provide a comprehensive approach to evaluating the pathogenesis of complex diseases, such as depression. OBJECTIVE: To identify the metabolic signatures of major depressive disorder (MDD), elucidate the direction of associations using mendelian randomization, and evaluate the interplay of the human gut microbiome and metabolome in the development of MDD. DESIGN, SETTING AND PARTICIPANTS: This cohort study used data from participants in the UK Biobank cohort (n = 500 000; aged 37 to 73 years; recruited from 2006 to 2010) whose blood was profiled for metabolomics. Replication was sought in the PREDICT and BBMRI-NL studies. Publicly available summary statistics from a 2019 genome-wide association study of depression were used for the mendelian randomization (individuals with MDD = 59 851; control individuals = 113 154). Summary statistics for the metabolites were obtained from OpenGWAS in MRbase (n = 118 000). To evaluate the interplay of the metabolome and the gut microbiome in the pathogenesis of depression, metabolic signatures of the gut microbiome were obtained from a 2019 study performed in Dutch cohorts. Data were analyzed from March to December 2021. MAIN OUTCOMES AND MEASURES: Outcomes were lifetime and recurrent MDD, with 249 metabolites profiled with nuclear magnetic resonance spectroscopy with the Nightingale platform. RESULTS: The study included 6811 individuals with lifetime MDD compared with 51 446 control individuals and 4370 individuals with recurrent MDD compared with 62 508 control individuals. Individuals with lifetime MDD were younger (median [IQR] age, 56 [49-62] years vs 58 [51-64] years) and more often female (4447 [65%] vs 2364 [35%]) than control individuals. Metabolic signatures of MDD consisted of 124 metabolites spanning the energy and lipid metabolism pathways. Novel findings included 49 metabolites, including those involved in the tricarboxylic acid cycle (ie, citrate and pyruvate). Citrate was significantly decreased (β [SE], -0.07 [0.02]; FDR = 4 × 10-04) and pyruvate was significantly increased (β [SE], 0.04 [0.02]; FDR = 0.02) in individuals with MDD. Changes observed in these metabolites, particularly lipoproteins, were consistent with the differential composition of gut microbiota belonging to the order Clostridiales and the phyla Proteobacteria/Pseudomonadota and Bacteroidetes/Bacteroidota. Mendelian randomization suggested that fatty acids and intermediate and very large density lipoproteins changed in association with the disease process but high-density lipoproteins and the metabolites in the tricarboxylic acid cycle did not. CONCLUSIONS AND RELEVANCE: The study findings showed that energy metabolism was disturbed in individuals with MDD and that the interplay of the gut microbiome and blood metabolome may play a role in lipid metabolism in individuals with MDD.
引用
- Amin N, Liu J, Bonnechere B, et al. Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals. JAMA Psychiatry. 2023. PMID: 37074710. doi:10.1001/jamapsychiatry.2023.0685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。